Universiteit Leiden

nl en

Leiden Academic Centre for Drug Research

The Leiden Academic Centre for Drug Research (LACDR) is a centre of excellence for multidisciplinary research on drug discovery and development.

Despite major advances in medicine- research, many common diseases such as cancers, neurological or cardiovascular diseases, or auto-immune diseases, still lack effective treatment, or are still often found incurable.

That is why our work to develop new and more effective drugs is essential. At the LACDR we work at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.


Our research is focused in three divisions:  Drug Discovery & Safety, BioTherapeutics and Systems Biomedicine and Pharmacology, which you can find below:


Combining the expertises of Biopharmaceutics and Drug Delivery Technology. Our research-focus lies on advancing innovative biopharmaceutical concepts to intervene in auto-immune-like disorders.

To the division of BioTherapeutics >

Drug Discovery & Safety

Incorporating the strengths of Toxicology and Medicinal Chemistry we focus on advanced imaging-based phenotypic screening for drug target and drug lead discovery. 

To the division of Drug Discovery & Safety >

Systems Biomedicine and Pharmacology

Conjoining the fields of Pharmacology  and Analytical Biosciences our research focusses on personalised medicine and the development of novel systems-based approaches in translational and clinical pharmacology.

To the division of Systems Biomedicine and Pharmacology >

Education in Biopharmaceutical Sciences

Our education ranges the Bachelor's and Master's programs in Bio-Pharmaceutical Sciences and the LACDR PhD program. We are committed to providing quality graduate experiences in a personalized environment of cutting edge research and internationally renowned supervisors.

Read more >


This website uses cookies. More information